Spondyloarthritis & psoriatic arthritis
Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis
Study context
- Population
- Patients with psoriatic disease (PsD)
Methodological detailsGroup for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting session
- GRAPPA 2022 annual meeting session
Main finding
As reported in the abstract
- Session discussed current understanding of the risk of severe COVID-19 in patients with PsD
- Effects of PsD and its treatment on prevention and treatment of COVID-19 with vaccinations, antiviral drugs and monoclonal antibodies were discussed
- Presentation on perspectives of patient research partners about their experiences with COVID-19
Original publication
Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis. J Rheumatol. Published 1 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →